Sublingual misoprostol to decrease blood loss after caesarean delivery: A randomised controlled trial

References

• Abou Zhar C, Royston E. 1991. Maternal mortality: a global fact book. Geneva: World Health Organization.
   Google Scholar
• Abu MMH. 2001. Obstetric haemorrhage. In: Lawson JB, Harrison KA, Bergston S, editors. Maternity care in developing countries. London: Royal College of Obstetrics and Gynaecology Press. p 160–168.
   Google Scholar
• Acharya G, Al-Sammarai MT, Patel N, Al-Habib A, Kiserud T. 2001. A randomized controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during caesarean section. Acta Obstetricia et Gynecologica Scandinavica80:245–250.
   PubMed Web of Science ®Google Scholar
• Blanchard K, Clark S, Winikoff B, Gaines G, Kabani G, Shannon C. 2002. Misoprostol for women's health: a review. Obstetrics and Gynaecology99:316–32
   PubMed Web of Science ®Google Scholar
• Bugalho A, Daniel A, Faundes A, Cunha M. 2001. Misoprostol for prevention of post partum haemorrhage. International Journal of Gynaecology and Obstetrics73:1–6.
   PubMed Web of Science ®Google Scholar
• Chaudhuri P, Banerjee GB, Mandal A. 2010. Rectally administered misoprostol versus intravenous oxytocin infusion during caesarean delivery to reduce intra-operative and post-operative blood loss. International Journal of Gynecology and Obstetrics109:25–29.
   PubMedGoogle Scholar
• Dansereau J, Joshi AK, Helewa ME, Doran TA, Lange IR, Luther ER et al. 1999. Double blind comparison of carbetocin versus oxytocin in prevention of uterine atony after caesarean section. American Journal of Obstetrics and Gynecology180:670–676.
   PubMed Web of Science ®Google Scholar
• DoH. 1998. Why Mothers Die: Report on confidential enquiries into maternal deaths in the United Kingdom 1994–1996. London: Department of Health. p 48–55.
   Google Scholar
• Gibbens D, Boyd NRH, Crocker S, Baumber S, Chard T. 1972. The circulating levels of oxytocin following intravenous and intramuscular administration of syntometrine. Journal of Obstetrics and Gynaecology of the British Commonwealth79:644–646.
   PubMedGoogle Scholar
• Hamm J, Russel Z, Botha T, Carlan SJ, Richichi K. 2005. Buccal misoprostol to prevent haemorrhage at caesarean delivery: A randomized study. American Journal of Obstetrics and Gynecology192:1404–1406.
   PubMed Web of Science ®Google Scholar
• Ijaiya MA, Aboyeji AP, Abubakar D. 2003. Analysis of 348 consecutive cases of primary post partum haemorrhage at a tertiary hospital in Nigeria. Journal of Obstetrics and Gynaecology23:374–377.
   Google Scholar
• Karim A. 1987. Antiulcer prostaglandin misoprostol: single and multiple dose pharmacokinetic profile. Prostaglandins33(Suppl):40–50.
   PubMedGoogle Scholar
• Lalonde AB, Daviss BA, Acosta A, Herschderfer K. 2006. Postpartum haemorrhage today: living in the shadow of the Taj Mahal. In: B-Lynch C, Keith LG, Lalonde AB, Karoshi M, editors. A textbook of post partum haemorrhage. Sapens Publishing, UK.
   Google Scholar
• Lapaire O, Schneider MC, Stotz M, Surbek DV, Holzgreve W, Hoesli IM. 2006. Oral misoprostol versus intravenous oxytocin in reducing blood loss after emergency caesarean delivery. International Journal of Gynaecology and Obstetrics95:2–7.
   PubMed Web of Science ®Google Scholar
• Lokugamage AU, Paine M, Bassaw-Balroop K, Sullivan KR, El Refaey H, Rodeck CH. 2001. Active management of the third stage at caesarean section: a randomized controlled trial of misoprostol versus syntocinon. Australian and New Zealand Journal of Obstetrics and Gynaecology41:411–414.
   PubMedGoogle Scholar
• Murin MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC. 2001. Comparison of two oxytocin regimens to prevent uterine atony at caesarean delivery: a randomized controlled trial. Obstetrics and Gynaecology98:386–390.
   Google Scholar
• Owonikoko KM, Arowojolu AO, Okunlola MA. 2011. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at caesarean section in Nigeria: A randomized controlled trial. Journal of Obstetrics and Gynaecology Research37:715–721.
   PubMed Web of Science ®Google Scholar
• Ray A, Mukherjee P, Basu G, Chatterjee A. 2001. Misoprostol and third stage of labour. Journal of Obstetrics and Gynaecology of India51:53–55.
   Google Scholar
• Ujah IAO, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE. 2005. Maternal mortality among adolescent women in Jos, North-Central Nigeria. Journal of Obstetrics and Gynaecology25:3–6.
   Google Scholar
• Ujah IAO, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE. 2006. Factors contributing to maternal mortality in North-Central Nigeria (1985–2001). African Journal of Reproductive Health9:27–40.
   Google Scholar
• Vimala N, Mittal S, Kumar S. 2006. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at caesarean section. International Journal of Gynaecology and Obstetrics92:106–110.
   PubMed Web of Science ®Google Scholar
• WHO. 2004. Maternal Mortality in 2000: Estimates developed by WHO, UNICEF and UNFPA. Geneva: World Health Organization.
   Google Scholar
• WHO. 2011. Trends in maternal mortality: 1990–2008: Estimates developed by the WHO, UNICEF, UNFPA and the World Bank. Geneva: World Health Organization. http://whqlibdoc.who.int/publications/2010/9789241500265_eng.pdf (accessed November 2013).
   Google Scholar
• Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. 1997. Absorption kinetics of misoprostol with oral or vaginal administration. Obstetrics and Gynaecology90:88–92.
   PubMed Web of Science ®Google Scholar